GENEVA, May 17 -- GUANGZHOU MAGPIE PHARMACEUTICALS CO., LTD. (Room F606, Guangzhou International Business Incubator, No.3 Lanyue Road, Science City, Huangpu DistrictGuangzhou, Guangdong 510005), 广州喜鹊医药有限公司 (中国广东省广州市黄埔区科学城揽月路3号广州国际企业孵化器F606室) filed a patent application (PCT/CN2024/128563) for "USE OF LIGUSTRAZINE NITRONE DERIVATIVE IN PREPARATION OF DRUG FOR PREVENTING OR TREATING SARCOPENIA" on Oct 30, 2024. With publication no. WO/2025/098219, the details related to the patent a...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.